Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Medical exposure to radiation and thyroid cancer.
Schonfeld SJ, Lee C, Berrington de González A. Schonfeld SJ, et al. Among authors: berrington de gonzalez a. Clin Oncol (R Coll Radiol). 2011 May;23(4):244-50. doi: 10.1016/j.clon.2011.01.159. Epub 2011 Feb 5. Clin Oncol (R Coll Radiol). 2011. PMID: 21296564 Review.
This trend has been hypothesised to reflect a combination of technological advances enabling increased detection, but also changes in environmental factors, including population exposure to ionising radiation from fallout, diagnostic tests and treatment for benign and mali …
This trend has been hypothesised to reflect a combination of technological advances enabling increased detection, but also changes in …
Comparison of documented and recalled histories of exposure to diagnostic x-rays in case-control studies of thyroid cancer.
Berrington de Gonzalez A, Ekbom A, Glass AG, Galanti MR, Grimelius L, Allison MJ, Inskip PD. Berrington de Gonzalez A, et al. Am J Epidemiol. 2003 Apr 1;157(7):652-63. doi: 10.1093/aje/kwg026. Am J Epidemiol. 2003. PMID: 12672685
The authors assessed agreement between medical x-ray histories obtained through interview and by review of medical records from thyroid cancer case-control studies conducted in Sweden (1985-1992; 123 cases and 123 controls) and from members of a prepaid health plan in the …
The authors assessed agreement between medical x-ray histories obtained through interview and by review of medical records from thyroid canc …
Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries.
Berrington de González A, Darby S. Berrington de González A, et al. Lancet. 2004 Jan 31;363(9406):345-51. doi: 10.1016/S0140-6736(04)15433-0. Lancet. 2004. PMID: 15070562
The calculations involved a number of assumptions and so are inevitably subject to considerable uncertainty. The possibility that we have overestimated the risks cannot be ruled out, but that we have underestimated them substantially seems unlikely....
The calculations involved a number of assumptions and so are inevitably subject to considerable uncertainty. The possibility that we …
Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits.
Berrington de González A, Reeves G. Berrington de González A, et al. Br J Cancer. 2005 Sep 5;93(5):590-6. doi: 10.1038/sj.bjc.6602683. Br J Cancer. 2005. PMID: 16136033 Free PMC article.
The corresponding estimate for screening starting at age 40 years was a net decrease of 0.46 deaths/1000 women screened and a zero net change assuming a 10% mortality reduction. ...Although these calculations were based on a number of uncertain paramet …
The corresponding estimate for screening starting at age 40 years was a net decrease of 0.46 deaths/1000 women screened and a
Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.
International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodhill A, Green J, Peto J, Plummer M, Sweetland S. International Collaboration of Epidemiological Studies of Cervical Cancer, et al. Among authors: berrington de gonzalez a. Lancet. 2007 Nov 10;370(9599):1609-21. doi: 10.1016/S0140-6736(07)61684-5. Lancet. 2007. PMID: 17993361 Review.
BACKGROUND: Combined oral contraceptives are classified by the International Agency for Research on Cancer as a cause of cervical cancer. ...A similar pattern of risk was seen both for invasive and in-situ cancer, and in women who tested positive for high-risk human …
BACKGROUND: Combined oral contraceptives are classified by the International Agency for Research on Cancer as a cause of cervical can …
Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study.
Berrington de Gonzalez A, Yun JE, Lee SY, Klein AP, Jee SH. Berrington de Gonzalez A, et al. Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):359-64. doi: 10.1158/1055-9965.EPI-07-0507. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18268120
There is increasing evidence that type 2 diabetes mellitus and glucose intolerance are a cause, not just a consequence, of pancreatic cancer. ...The association with elevated liver enzyme levels is a novel finding that warrants further investigation....
There is increasing evidence that type 2 diabetes mellitus and glucose intolerance are a cause, not just a consequence, of pan …
Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk.
Berrington de González A, Kim KP, Berg CD. Berrington de González A, et al. J Med Screen. 2008;15(3):153-8. doi: 10.1258/jms.2008.008052. J Med Screen. 2008. PMID: 18927099 Free PMC article.
Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers.
Meinhold CL, Berrington de Gonzalez A, Albanes D, Weinstein SJ, Taylor PR, Virtamo J, Stolzenberg-Solomon RZ. Meinhold CL, et al. Among authors: berrington de gonzalez a. Cancer Causes Control. 2009 Jul;20(5):681-90. doi: 10.1007/s10552-008-9281-z. Epub 2008 Dec 13. Cancer Causes Control. 2009. PMID: 19083105 Free PMC article. Clinical Trial.
OBJECTIVES: A history of type 2 diabetes is one of few consistent risk factors for pancreatic cancer. Potentially modifiable factors related to fasting insulin and glucose concentrations may influence pancreatic cancer risk. METHODS: Multiple linear regression models were …
OBJECTIVES: A history of type 2 diabetes is one of few consistent risk factors for pancreatic cancer. Potentially modifiable factors …
Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.
Berrington de Gonzalez A, Berg CD, Visvanathan K, Robson M. Berrington de Gonzalez A, et al. J Natl Cancer Inst. 2009 Feb 4;101(3):205-9. doi: 10.1093/jnci/djn440. Epub 2009 Jan 27. J Natl Cancer Inst. 2009. PMID: 19176458
We used an excess relative risk model (based on a pooled analysis of three cohorts with 7600 subjects who received radiation exposure) to estimate the lifetime risk of radiation-induced breast cancer from five annual mammographic screenings in young (<40 years) BRCA mut …
We used an excess relative risk model (based on a pooled analysis of three cohorts with 7600 subjects who received radiation exposure …
Risks associated with low doses and low dose rates of ionizing radiation: why linearity may be (almost) the best we can do.
Little MP, Wakeford R, Tawn EJ, Bouffler SD, Berrington de Gonzalez A. Little MP, et al. Among authors: berrington de gonzalez a. Radiology. 2009 Apr;251(1):6-12. doi: 10.1148/radiol.2511081686. Radiology. 2009. PMID: 19332841 Free PMC article. No abstract available.
152 results
Jump to page
Feedback